Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021).

ABSTRACT:

Objectives

The aim of this study was to perform a descriptive analysis of oropharyngeal adverse events (AEs) related to drugs and/or vaccines in order to provide useful information for clinicians.

Methods

Data related to three regions of Italy were analyzed from 2019 to 2021 by using the National Pharmacovigilance database.

Results

Among overall 67,384 cases, 2773 (4.1%) reported at least one oropharyngeal AE. Most cases referred to females (71.0%) and adults (70.8%). The majority of cases were reported as not serious (68.4%) and the outcome was mainly positive (73.5%). The cases related to drugs (52.2%) were slightly more than those related to vaccines (47.8%), the latter nearly completely represented by COVID-19 vaccines. Among 3324 oropharyngeal AEs, the most commo

SUBMITTER: Sportiello L 

PROVIDER: S-EPMC12021317 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature